Riskpilot← Back to searchSign inGet full accessBREEDSENSE AS
ASActiveOrg 923768076Fosseikeveien 24, 4323 SandnesResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20190 employees
Revenue 2024
NOK 39K
-44% vs 2023
EBITDA margin
73.8%
+199% vs 2023
Equity ratio
-4397.3%
Financial strength
Net profit 2024
NOK -181K
+20% vs 2023
| Revenue | NOK 39K | -44% |
| EBITDA | NOK 28K | +199% |
| Net profit | NOK -181K | +20% |
| Total assets | NOK 77K | +3% |
| Equity | NOK -3,4M | -6% |
| Employees | 0 | — |
Legal name
BREEDSENSE AS
Org number
923768076
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5. november 2019
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Forskning og utvikling av produkter og tjenester innen veterinær- og landbrukssektoren for salg i et internasjonalt marked. Selskapet skal drive med konsulenttjenester, utleie av lab og labutstyr. Selskapet skal også investere i andre selskaper og alt som dertil står i forbindelse.
Address
Fosseikeveien 24, 4323 Sandnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 60 | 43 | 60 | 68 | 39 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −1 065 | −869 | −753 | −29 | 28 |
| Depreciation & amort. | −0 | −34 | −48 | −48 | −15 | −7 |
| EBIT | −6 | −1 099 | −917 | −801 | −44 | 22 |
| Net financials | 0 | −24 | −36 | −132 | −182 | −203 |
| Profit before tax | −6 | −1 123 | −954 | −933 | −226 | −181 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 | −1 123 | −954 | −933 | −226 | −181 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 21 | 466 | 154 | 140 | 75 | 77 |
| Equity | 13 | −1 110 | −2 064 | −2 997 | −3 223 | −3 405 |
| Long-term debt | 0 | 1 500 | 2 100 | 3 000 | 3 000 | 3 000 |
| Short-term debt | 8 | 75 | 118 | 137 | 298 | 482 |
| Total debt | 8 | 1 575 | 2 218 | 3 137 | 3 298 | 3 482 |
EBITDA margin
73.8%
This company
15.8%
Market median
+367% vs market
20192024
Equity ratio
-4397.3%
This company
38.2%
Market median
-11611% vs market
20192024
Return on equity
-18122600.0%
This company
18.4%
Market median
-98492491% vs market
20192024
Net profit margin
-469.4%
This company
8.1%
Market median
-5895% vs market
20192024
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20192024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-09-30 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KL Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Biolink Group As | Company | 51.0% | 51.0% | 2024 |
Oracow Inc. | Company | 49.0% | 49.0% | 2023 |
Dorothee Goldman | Company | 36.3% | 36.3% | 2024 |
Craig Laramee | Company | 9.1% | 9.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BREEDSENSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Larsen | Chief Executive Officer | 0 companies |
| Svein Ove Føyen | Board of Directors | 0 companies |
| Kåre Svaboe | Board of Directors | 0 companies |
| Sjur Svaboe | Chairman | 0 companies |
| Linn Kathrine Høiland Sagerup | Board of Directors | 0 companies |
| Torleiv Bilstad | Board of Directors | 0 companies |